Provided by Tiger Fintech (Singapore) Pte. Ltd.

vTv Therapeutics

16.00
-0.5400-3.26%
Post-market: 16.000.00000.00%16:04 EDT
Volume:1.53K
Turnover:24.55K
Market Cap:112.78M
PE:-5.64
High:16.31
Open:16.25
Low:16.00
Close:16.54
Loading ...
May 12, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 07, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 24, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Apr 07, 2020

Major Issues Report

Current report, item 1.01
Feb 25, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 25, 2020

Major Issues Report

Current report, item 3.02
Feb 21, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 21, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2020

Major Issues Report

Current report, item 3.02
Jan 28, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 07, 2020

Major Issues Report

Current report, item 3.02
Jan 07, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 23, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 23, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 3.02
Dec 18, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 18, 2019

Major Issues Report

Current report, item 3.02
Nov 29, 2019

Major Issues Report

Current report, item 5.02
Nov 26, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership